Lifemd Inc (LFMD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access LFMD Annual Cash Flow →
Tracking cash flow results across Lifemd Inc to Jun 30 2025 helps illustrate how Jun 30 2026's cash generation has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-33.47
Depreciation & amortization0.58
Amortization of Other Assets0.06
Increase (Decrease) in Deferred Revenue-0.02
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.18
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Conversion Of Stock Amount Issued-
Gain Loss On Discontinued Operations And Disposal-
Stock Issued For Services-
Warrant Revaluation-
Operating Lease Payments-
Capitalized Computer Software Amortization1.67
Acceleration Of Debt Discount-
Operating Lease Payments Adjustments0.21
Liability To Issue Shares For Services-
Gain On Debt Forgiveness-
Sales Returns Reserve-
Increase Decrease In Contract With Customer Asset-0.01
Increase Decrease In Operating Lease Liability-0.15
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable1.95
Increase (Decrease) in Accounts Payable4.01
Increase (Decrease) in Accrued Liabilities0.99
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-0.16
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities19.39
Discontinued operations0.00
Net Cash flow from Operating Activities-6.48
Investing Activities
Capital Expenditures-3.70
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payment For Contingent Consideration Liability Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.01
Discontinued operations0.00
Net Cash Flow from Investing Activities-3.69
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.08
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments For Proceeds From Deposit-
Stock Issued During Period Value Stock Options Exercised-
Issuance Of Common Stock And Warrants-
Distributions To Noncontrolling Interest-
Proceeds From Cash Receipts From Investors For Unissued Shares-
Payments For Distributions To Noncontrolling Interest-
Proceeds From Shares And Warrants-
Purchase Of Membership Interest Of Lss-
Purchase Of Membership Interest Of Worksimpli-
Cash Proceeds From Series Preferred And Common Stock Offering-
Cash Proceeds From Series B Convertible Preferred Stock-
Proceeds From Issuance Of Common Stock Under At The Market-
Purchase Of Membership Interest-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-1.55
Net Cash Flow from Financing Activities-1.47
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-10.18
Total Cash Flow-11.64
4 historic quarters locked

Sign in to unlock the full Lifemd Inc cash flow history.

About Lifemd Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 5, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-036200

Figures are derived from filed reports and may be restated. Historical data is subject to revision.